Xing Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xing Liang has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Junyu Chen
State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No. 14, Section 3, South Renmin Road, Chengdu 610041, Sichuan Province, China
3 shared publications Weiqing Liu
State Key Laboratory of Oral Diseases National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu China
3 shared publicationsAi Tian
From the State Key Laboratory of Oral Diseases (Sun, Liao, Teng, Tian, Liang), West China Hospital of Stomatology, Sichuan University, Sichuan and the Stomatological Department (Zhai), Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China
2 shared publicationsDutmanee Seriwatanachai
Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand
2 shared publicationsHe Cai
Department of Prosthodontics, West China Hospital of Stomatology, State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Sichuan University, No. 14, Section 3, South Renmin Road, Chengdu, 610041, China
2 shared publications- Jian Liao
Department of Prosthodontics and Implantology The Affiliated Stomatological Hospital of Guizhou Medical University, Guizhou Medical University Guiyang PR China
2 shared publications
Latest Publications
- 20 November 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (1) , 019502
Corrigendum: Mechanical and degradative properties of PLDLA biodegradable pins with bioactive glass fibers in a beagle model (2022 Biomed. Mater. 15 035010)
Corrigendum: Mechanical and degradative properties of PLDLA biodegradable pins with bioactive glass fibers in a beagle model (2022 Biomed. Mater. 15 035010), Wang, Yue, Wu, Peng, Sun, Dongyuan, Luo, Youran, Chen, Cheng, Tang, Ziqing, Liao, Yunmao, Cao, Xiaoyan, Cheng, Chengkung, Liu, Weiqing, Liang, Xing
- 20 November 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (1) , 019502
Corrigendum: Mechanical and degradative properties of PLDLA biodegradable pins with bioactive glass fibers in a beagle model (2022 Biomed. Mater. 15 035010)
Corrigendum: Mechanical and degradative properties of PLDLA biodegradable pins with bioactive glass fibers in a beagle model (2022 Biomed. Mater. 15 035010), Wang, Yue, Wu, Peng, Sun, Dongyuan, Luo, Youran, Chen, Cheng, Tang, Ziqing, Liao, Yunmao, Cao, Xiaoyan, Cheng, Chengkung, Liu, Weiqing, Liang, Xing
- 2 March 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (4) , 667-678
Hyperglycemia accelerates inflammaging in the gingival epithelium through inflammasomes activation
Background and Objective: Diabetes accelerates inflammaging in various tissue with an increase in senescent cell burden and senescence‐associated secretory phenotype (SASP) secretion, which is a significant cause of tissue dysfunction and contributes to the diabetic complications. Recently, inflammasomes are thought to contribute to inflammaging. Here, utilizing diabetic models in vivo and in vitro, we investigated the potential association between hyperglycemia‐induced inflammaging and gingival tissue dysfunction and the mechanism underlying inflammasome‐associated inflammaging.Materials and Methods: Gingival epithelium and serum were collected from control and diabetic patients and mice. The expression of p16, p21, and inflammasomes in the gingival epithelium, SASP factors in serum, and the molecular factors associated with gingival epithelial barrier function were assessed. Human oral keratinocyte (HOK) was stimulated with normal and high glucose, and pre‐treated with Z‐YVAD‐FMK (Caspase‐1 inhibitor) prior to evaluating cellular senescence, SASP secretion, and inflammasome activation.Results: In vivo, hyperglycemia significantly elevated the local burden of senescent cells in the gingival epithelium and SASP factors in the serum and simultaneously reduced the expression levels of Claudin‐1, E‐cadherin, and Connexin 43 in the gingival epithelium. Interestingly, the inflammasomes were activated in the gingival epithelium. In vitro, high glucose‐induced the inflammaging in HOK, and blocking inflammasome activation through inhibiting Caspase‐1 and glucose‐induced inflammaging.Conclusions: Hyperglycemia accelerated inflammaging in the gingival epithelium through inflammasomes activation, which is potentially affiliated with a decline in the gingival epithelial barrier function in diabetes. Inflammasomes‐related inflammaging may be the crucial mechanism underlying diabetic periodontitis and represents significant opportunities for advancing prevention and treatment options.
- 2 March 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (4) , 667-678
Hyperglycemia accelerates inflammaging in the gingival epithelium through inflammasomes activation
Background and Objective: Diabetes accelerates inflammaging in various tissue with an increase in senescent cell burden and senescence‐associated secretory phenotype (SASP) secretion, which is a significant cause of tissue dysfunction and contributes to the diabetic complications. Recently, inflammasomes are thought to contribute to inflammaging. Here, utilizing diabetic models in vivo and in vitro, we investigated the potential association between hyperglycemia‐induced inflammaging and gingival tissue dysfunction and the mechanism underlying inflammasome‐associated inflammaging.Materials and Methods: Gingival epithelium and serum were collected from control and diabetic patients and mice. The expression of p16, p21, and inflammasomes in the gingival epithelium, SASP factors in serum, and the molecular factors associated with gingival epithelial barrier function were assessed. Human oral keratinocyte (HOK) was stimulated with normal and high glucose, and pre‐treated with Z‐YVAD‐FMK (Caspase‐1 inhibitor) prior to evaluating cellular senescence, SASP secretion, and inflammasome activation.Results: In vivo, hyperglycemia significantly elevated the local burden of senescent cells in the gingival epithelium and SASP factors in the serum and simultaneously reduced the expression levels of Claudin‐1, E‐cadherin, and Connexin 43 in the gingival epithelium. Interestingly, the inflammasomes were activated in the gingival epithelium. In vitro, high glucose‐induced the inflammaging in HOK, and blocking inflammasome activation through inhibiting Caspase‐1 and glucose‐induced inflammaging.Conclusions: Hyperglycemia accelerated inflammaging in the gingival epithelium through inflammasomes activation, which is potentially affiliated with a decline in the gingival epithelial barrier function in diabetes. Inflammasomes‐related inflammaging may be the crucial mechanism underlying diabetic periodontitis and represents significant opportunities for advancing prevention and treatment options.
- Open Access
- 8 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-2
Author Correction: Chronic Kidney Disease Impairs Bone Defect Healing in Rats
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 8 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-2
Open AccessAuthor Correction: Chronic Kidney Disease Impairs Bone Defect Healing in Rats
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 8 April 2020
- Published by Wiley in Oral Diseases
- Vol. 27 (4) , 829-847
Efficacy of aromatherapy on dental anxiety: A systematic review of randomised and quasi‐randomised controlled trials
Objectives To evaluate the efficacy of aromatherapy on dental anxiety. Methods A detailed protocol was registered a priori (PROSPERO: CRD42019141093). PubMed, EMBASE, CDSR, CENTRAL, CNKI and grey literature databases were searched from inception to 10 January 2020. Randomised controlled trials (RCTs) and quasi‐randomised controlled trials (CCTs) that examined the effects of aromatherapy on dental anxiety, compare to either negative control (i.e. no aromatherapy) or other positive control approaches (e.g. music), were included. The risk of bias of the selected studies was evaluated using the Cochrane Collaboration’s tool and ROBINS‐I whilst the certainty of evidence was assessed using GRADE. A narrative synthesis was performed, rather than meta‐analysis, due to the high level of heterogeneity across studies. Results Eleven RCTs and six CCTs were included. The risk of bias was identified as either high or unclear in RCTs, and moderate to serious in CCTs. Performance bias and detection bias were the most prevalent in RCTs, followed by selection bias and reporting bias. As to CCTs, greater risk of bias was found in the selection of participants into the study and in the measurement of outcomes. Based on the selected studies, the most commonly used aromatherapy for dental anxiety management was lavender fragrance, followed by orange. Compared to the negative control condition, aromatherapy might reduce the anxiety‐related physiological parameters and psychometric rating, pain, and mood, alertness, and calmness compared to the negative control condition; and there might be no intergroup difference in such outcomes between aromatherapy and music. However, GRADEs of the relevant evidence were judged as low to very low. Conclusions Compared to the negative control condition, aromatherapy is more effective to reduce dental anxiety and, has comparable effects on dental anxiety compared to music intervention; however, the certainty of evidence is relatively limited. Further high‐quality randomised trials with robust study design and large sample size are warranted to confirm our findings and to confirm the role of aromatherapy in relieving dental anxiety.
- 8 April 2020
- Published by Wiley in Oral Diseases
- Vol. 27 (4) , 829-847
Efficacy of aromatherapy on dental anxiety: A systematic review of randomised and quasi‐randomised controlled trials
Objectives To evaluate the efficacy of aromatherapy on dental anxiety. Methods A detailed protocol was registered a priori (PROSPERO: CRD42019141093). PubMed, EMBASE, CDSR, CENTRAL, CNKI and grey literature databases were searched from inception to 10 January 2020. Randomised controlled trials (RCTs) and quasi‐randomised controlled trials (CCTs) that examined the effects of aromatherapy on dental anxiety, compare to either negative control (i.e. no aromatherapy) or other positive control approaches (e.g. music), were included. The risk of bias of the selected studies was evaluated using the Cochrane Collaboration’s tool and ROBINS‐I whilst the certainty of evidence was assessed using GRADE. A narrative synthesis was performed, rather than meta‐analysis, due to the high level of heterogeneity across studies. Results Eleven RCTs and six CCTs were included. The risk of bias was identified as either high or unclear in RCTs, and moderate to serious in CCTs. Performance bias and detection bias were the most prevalent in RCTs, followed by selection bias and reporting bias. As to CCTs, greater risk of bias was found in the selection of participants into the study and in the measurement of outcomes. Based on the selected studies, the most commonly used aromatherapy for dental anxiety management was lavender fragrance, followed by orange. Compared to the negative control condition, aromatherapy might reduce the anxiety‐related physiological parameters and psychometric rating, pain, and mood, alertness, and calmness compared to the negative control condition; and there might be no intergroup difference in such outcomes between aromatherapy and music. However, GRADEs of the relevant evidence were judged as low to very low. Conclusions Compared to the negative control condition, aromatherapy is more effective to reduce dental anxiety and, has comparable effects on dental anxiety compared to music intervention; however, the certainty of evidence is relatively limited. Further high‐quality randomised trials with robust study design and large sample size are warranted to confirm our findings and to confirm the role of aromatherapy in relieving dental anxiety.
- Open Access
- 20 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 2829854
Effects of Herbal Mouthwashes on Plaque and Inflammation Control for Patients with Gingivitis: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Objective. The aim of this study was to evaluate the overall effects of herbal mouthwashes as supplements to daily oral hygiene on plaque and inflammation control compared with placebos and chlorhexidine (CHX) mouthwashes in the treatment of gingivitis. Methods. PubMed, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and grey literature databases were searched. Only randomised controlled trials (RCTs) comparing herbal mouthwashes with placebos or CHX in the daily oral hygiene of patient with gingivitis were included to compare the effect of different mouthwashes on plaque and inflammation control. Results. A total of 13 studies satisfied the eligibility criteria, and 11 studies were included in meta‐analyses. Significant differences were observed in favour of herbal mouthwashes compared with placebos in both plaque‐ and inflammation‐related indices (Quigley‐Hein Plaque Index, QHPI: WMD = −0.61, 95% CI (−0.80, −0.42), P < 0.001; Gingival Index, GI: −0.28 (−0.51, −0.06), P = 0.01; Modified Gingival Index, MGI: −0.59 (−1.08, −0.11), P = 0.02; Gingival Bleeding Index, GBI: −0.06 (−0.09, −0.04), P < 0.001). No significant difference was found between herbal and CHX mouthwashes. Conclusions. Herbal mouthwashes have potential benefits in plaque and inflammation control as supplements to the daily oral hygiene of patients with gingivitis. Although no difference was observed between herbal and CHX mouthwashes in the selected studies, further high‐quality RCTs are needed for more firm support before advising patients with gingivitis about whether they can use herbal mouthwashes to substitute for CHX mouthwashes or not (PROSPERO registration number: CRD42019122841).
- 20 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 2829854
Open AccessEffects of Herbal Mouthwashes on Plaque and Inflammation Control for Patients with Gingivitis: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Objective. The aim of this study was to evaluate the overall effects of herbal mouthwashes as supplements to daily oral hygiene on plaque and inflammation control compared with placebos and chlorhexidine (CHX) mouthwashes in the treatment of gingivitis. Methods. PubMed, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and grey literature databases were searched. Only randomised controlled trials (RCTs) comparing herbal mouthwashes with placebos or CHX in the daily oral hygiene of patient with gingivitis were included to compare the effect of different mouthwashes on plaque and inflammation control. Results. A total of 13 studies satisfied the eligibility criteria, and 11 studies were included in meta‐analyses. Significant differences were observed in favour of herbal mouthwashes compared with placebos in both plaque‐ and inflammation‐related indices (Quigley‐Hein Plaque Index, QHPI: WMD = −0.61, 95% CI (−0.80, −0.42), P < 0.001; Gingival Index, GI: −0.28 (−0.51, −0.06), P = 0.01; Modified Gingival Index, MGI: −0.59 (−1.08, −0.11), P = 0.02; Gingival Bleeding Index, GBI: −0.06 (−0.09, −0.04), P < 0.001). No significant difference was found between herbal and CHX mouthwashes. Conclusions. Herbal mouthwashes have potential benefits in plaque and inflammation control as supplements to the daily oral hygiene of patients with gingivitis. Although no difference was observed between herbal and CHX mouthwashes in the selected studies, further high‐quality RCTs are needed for more firm support before advising patients with gingivitis about whether they can use herbal mouthwashes to substitute for CHX mouthwashes or not (PROSPERO registration number: CRD42019122841).
- Open Access
- 27 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (3) , 4644-4653
microRNA‐211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein
Oral squamous cell carcinoma (OSCC), the most common pathological type of oral cancer, is still a frequent malignancy with unsatisfactory prognosis. Accumulating studies have proven some microRNAs (miRNAs) can function as oncogenes in OSCC by targeting tumor suppressors. In this study, we first investigated the expression and role of tumor suppressor bridging integrator‐1 (BIN1) in OSCC tissues and cells. Our results indicated that BIN1 was low expressed in the OSCC tissues and cell lines (SCC6, SCC9, SCC25, HN4, and HN6) along with miR‐211 was highly expressed in OSCC tissues and cell lines, and BIN1 overexpression could evidently inhibit their proliferation, migration, and invasion abilities. Next, we used bioinformation algorithms to predict the potential miRNA targeting BIN1 and chose miR‐211 for further study. miR‐211, a highly expressed miRNA in OSCC cells, could specifically bind with the 3′‐untranslated region (3′‐UTR) of BIN1 to trigger its degradation. Addition of miR‐211 inhibitor could evidently suppress the malignant behaviors of OSCC cells by upregulating BIN1 expression and inhibit the activation of the EGFR/MAPK pathway. Taken together the findings of the study indicated that miR‐211 mediated BIN1 downregulation had crucial significances in OSCC, suggesting the miR‐211 might be a novel potential therapeutic target for the OSCC treatment.
- 27 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (3) , 4644-4653
Open AccessmicroRNA‐211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein
Oral squamous cell carcinoma (OSCC), the most common pathological type of oral cancer, is still a frequent malignancy with unsatisfactory prognosis. Accumulating studies have proven some microRNAs (miRNAs) can function as oncogenes in OSCC by targeting tumor suppressors. In this study, we first investigated the expression and role of tumor suppressor bridging integrator‐1 (BIN1) in OSCC tissues and cells. Our results indicated that BIN1 was low expressed in the OSCC tissues and cell lines (SCC6, SCC9, SCC25, HN4, and HN6) along with miR‐211 was highly expressed in OSCC tissues and cell lines, and BIN1 overexpression could evidently inhibit their proliferation, migration, and invasion abilities. Next, we used bioinformation algorithms to predict the potential miRNA targeting BIN1 and chose miR‐211 for further study. miR‐211, a highly expressed miRNA in OSCC cells, could specifically bind with the 3′‐untranslated region (3′‐UTR) of BIN1 to trigger its degradation. Addition of miR‐211 inhibitor could evidently suppress the malignant behaviors of OSCC cells by upregulating BIN1 expression and inhibit the activation of the EGFR/MAPK pathway. Taken together the findings of the study indicated that miR‐211 mediated BIN1 downregulation had crucial significances in OSCC, suggesting the miR‐211 might be a novel potential therapeutic target for the OSCC treatment.
- Open Access
- 9 March 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 23041
Chronic Kidney Disease Impairs Bone Defect Healing in Rats
Chronic kidney disease (CKD) has been regarded as a risk for bone health. The aim of this study was to evaluate the effect of CKD on bone defect repair in rats. Uremia was induced by subtotal renal ablation and serum levels of BUN and PTH were significantly elevated four weeks after the second renal surgery. Calvarial defects of 5-mm diameter were created and implanted with or without deproteinized bovine bone mineral (DBBM). Micro-CT and histological analyses consistently revealed a decreased newly regenerated bone volume for CKD rats after 4 and 8 weeks. In addition, 1.4-mm-diameter cortical bone defects were established in the distal end of femora and filled with gelatin sponge. CKD rats exhibited significantly lower values of regenerated bone and bone mineral density (BMD) within the cortical gap after 2 and 4 weeks. Moreover, histomorphometric analysis showed an increase in both osteoblast number (N.Ob/B.Pm) and osteoclast number (N.Oc/B.Pm) in CKD groups due to hyperparathyroidism. Notably, collagen maturation was delayed in CKD rats as verified by Masson’s Trichrome staining. These data indicate that declined renal function negatively affects bone regeneration in both calvarial and femoral defects.
- 9 March 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 23041
Open AccessChronic Kidney Disease Impairs Bone Defect Healing in Rats
Chronic kidney disease (CKD) has been regarded as a risk for bone health. The aim of this study was to evaluate the effect of CKD on bone defect repair in rats. Uremia was induced by subtotal renal ablation and serum levels of BUN and PTH were significantly elevated four weeks after the second renal surgery. Calvarial defects of 5-mm diameter were created and implanted with or without deproteinized bovine bone mineral (DBBM). Micro-CT and histological analyses consistently revealed a decreased newly regenerated bone volume for CKD rats after 4 and 8 weeks. In addition, 1.4-mm-diameter cortical bone defects were established in the distal end of femora and filled with gelatin sponge. CKD rats exhibited significantly lower values of regenerated bone and bone mineral density (BMD) within the cortical gap after 2 and 4 weeks. Moreover, histomorphometric analysis showed an increase in both osteoblast number (N.Ob/B.Pm) and osteoclast number (N.Oc/B.Pm) in CKD groups due to hyperparathyroidism. Notably, collagen maturation was delayed in CKD rats as verified by Masson’s Trichrome staining. These data indicate that declined renal function negatively affects bone regeneration in both calvarial and femoral defects.
- Open Access
- 1 October 2014
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 35 (10) , 1195-1202
Masticatory efficiency and oral health-related quality of life with implant-retained mandibular overdentures
OBJECTIVES: To evaluate masticatory efficiency (ME) and oral health-related quality of life (OHRQoL) in patients rehabilitated with implant-retained mandibular overdentures. METHODS: In this randomized controlled clinical trial, 50 edentulous patients visiting the Implant Center and Department of Prosthodontics, West China College of Stomatology, Sichuan University, Chengdu, China between June 2010 and June 2012 were selected and received 2 implant-retained mandibular overdenture treatments. All patients were rehabilitated with maxillary complete dentures. The ME and OHRQoL were determined both one month before the mandibular complete denture was anchored to the osseointegrated implants, and 6 months after anchoring. Paired t-tests were used to compare means of ME, and oral health impact profile-49 (OHIP-49) domains scores between pre- and post-implant. Linear regression models were utilized to seek correlations between ME and OHIP domains scores. RESULTS: The ME increased from pre- to post-implant retained mandibular overdentures significantly (p<0.001). The total OHIP score and 4 subscales scores were changed significantly from pre- to post-implant; namely, functional limitation, psychological discomfort, physical disability, and physical pain. The total OHIP score, functional limitation, physical disability, and physical pain subscale scores were related to ME. CONCLUSION: Implant-retained mandibular over dentures can significantly improve patients’ ME and OHRQoL. The improvement in OHRQoL is mainly because of the improved ME. An improved chewing experience, and pain relief also contributes to improvement of OHRQoL.
- 1 October 2014
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 35 (10) , 1195-1202
Open AccessMasticatory efficiency and oral health-related quality of life with implant-retained mandibular overdentures
OBJECTIVES: To evaluate masticatory efficiency (ME) and oral health-related quality of life (OHRQoL) in patients rehabilitated with implant-retained mandibular overdentures. METHODS: In this randomized controlled clinical trial, 50 edentulous patients visiting the Implant Center and Department of Prosthodontics, West China College of Stomatology, Sichuan University, Chengdu, China between June 2010 and June 2012 were selected and received 2 implant-retained mandibular overdenture treatments. All patients were rehabilitated with maxillary complete dentures. The ME and OHRQoL were determined both one month before the mandibular complete denture was anchored to the osseointegrated implants, and 6 months after anchoring. Paired t-tests were used to compare means of ME, and oral health impact profile-49 (OHIP-49) domains scores between pre- and post-implant. Linear regression models were utilized to seek correlations between ME and OHIP domains scores. RESULTS: The ME increased from pre- to post-implant retained mandibular overdentures significantly (p<0.001). The total OHIP score and 4 subscales scores were changed significantly from pre- to post-implant; namely, functional limitation, psychological discomfort, physical disability, and physical pain. The total OHIP score, functional limitation, physical disability, and physical pain subscale scores were related to ME. CONCLUSION: Implant-retained mandibular over dentures can significantly improve patients’ ME and OHRQoL. The improvement in OHRQoL is mainly because of the improved ME. An improved chewing experience, and pain relief also contributes to improvement of OHRQoL.